Cargando…
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
Hearing loss caused by aging, noise, cisplatin toxicity, or other insults affects 360 million people worldwide, but there are no Food and Drug Administration–approved drugs to prevent or treat it. We screened 4,385 small molecules in a cochlear cell line and identified 10 compounds that protected ag...
Autores principales: | Teitz, Tal, Fang, Jie, Goktug, Asli N., Bonga, Justine D., Diao, Shiyong, Hazlitt, Robert A., Iconaru, Luigi, Morfouace, Marie, Currier, Duane, Zhou, Yinmei, Umans, Robyn A., Taylor, Michael R., Cheng, Cheng, Min, Jaeki, Freeman, Burgess, Peng, Junmin, Roussel, Martine F., Kriwacki, Richard, Guy, R. Kiplin, Chen, Taosheng, Zuo, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881471/ https://www.ncbi.nlm.nih.gov/pubmed/29514916 http://dx.doi.org/10.1084/jem.20172246 |
Ejemplares similares
-
High-Throughput Screening Reveals Alsterpaullone, 2-Cyanoethyl as a Potent p27(Kip1) Transcriptional Inhibitor
por: Walters, Brandon J., et al.
Publicado: (2014) -
Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015) -
8-Triazolylpurines: Towards Fluorescent Inhibitors of the MDM2/p53 Interaction
por: Pettersson, Mariell, et al.
Publicado: (2015) -
BRAF inhibition protects against hearing loss in mice
por: Ingersoll, Matthew A., et al.
Publicado: (2020) -
Progress in the
Development of Preventative Drugs
for Cisplatin-Induced Hearing Loss: Miniperspective
por: Hazlitt, Robert A., et al.
Publicado: (2018)